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SpineIncreased prevalence of mental disorders cannot be solely attributed to genetic factors and is considered at least
partly attributable to chemical exposure. Among various environmental chemicals, in utero and lactational dioxin
exposure has been extensively studied and is known to induce higher brain function abnormalities in both
humans and laboratory animals. However, how the perinatal dioxin exposure affects neuromorphological alter-
ations has remained largely unknown. Therefore, in this study, we initially studied whether and how the over-
expression of aryl hydrocarbon receptor (AhR), a dioxin receptor, would affect the dendritic growth in the hip-
pocampus of the developing brain. Transfecting a constitutively active AhR plasmid into the hippocampus via
in utero electroporation on gestational day (GD) 14 induced abnormal dendritic branch growth. Further, we ob-
served that 14-day-old mice born to dams administered with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; dose:
0, 0.6, or 3.0 μg/kg) onGD12.5 exhibited disrupted dendritic branch growth in both the hippocampus and amyg-
dala. Finally, we observed that 16-month-old mice born to dams exposed to perinatal TCDD as described above
exhibited signiﬁcantly reduced spine densities. These results indicated that abnormal micromorphology ob-
served in the developing brain may persist until adulthood and may induce abnormal higher brain function
later in life.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Environmental factors, such as nutritional and psychological condi-
tions during the fetal period, have been shown to impact health and dis-
ease conditions later in adulthood (Barker et al., 1989; Entringer et al.,
2009; Veening et al., 2003); this is now known as the theory of develop-
mental origins of health and disease (DOHaD). Evidence to support this
theory was originally established from the nutritional conditions of
pregnant mothers but has been extended to include chemical exposure
(Haugen et al., 2014). The extent of chemical exposure on the develop-
ing brain, which might result in pathogenesis of mental disorders, has
been reported to be considerably large and dependent on exposure con-
ditions, such as the chemical species, dose, and time of exposure (Lidow
and Song, 2001; Szpir, 2006; Yang et al., 2012). To date, exposure to lowboratory, Faculty of Medicine,
, Japan.
).
. This is an open access article underdoses of chemicals, such as dioxin, methylmercury, and lead, during the
prenatal period does not manifest conspicuous abnormalities in
mothers and fetuses, such exposure affects mental disorders later in
life (Grandjean and Landrigan, 2014; Patandin et al., 1999; Stewart
et al., 2008). Because the developmental process of the central nervous
system is orchestrated to proceed on a ﬁnely controlled timeframe and
in a correct sequence (Rice and Barone, 2000; Wong and Ghosh, 2002),
chemical exposure during a critical phase of the brain development
could induce deviation of the neural network, leading to higher brain
function abnormalities.
Adult rodent offspring born to dams exposed to low doses of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), the most toxic congener among
29 dioxin congeners (Van den Berg et al., 1998), was found to manifest
in cognitive and behavioral abnormalities, such as spatial, reversal and
alternate, and paired associate learning and memory, as well as anxiety
and sociality (Endo et al., 2012; Haijima et al., 2010; Hojo et al., 2002;
Kakeyama et al., 2014; Markowski et al., 2001; Mitsui et al., 2006;
Schantz et al., 1996). Previous studies have shown that in utero andthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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and BDNF in the hippocampus and cerebral cortex (Hood et al., 2006;
Kakeyama et al., 2001, 2003) and induce an imbalance of neural activity
between themedial prefrontal cortex and amygdala (Endo et al., 2012).
Although it is plausible to hypothesize that there are some alterations
in morphology, there is a notable paucity of neuromorphological
evidence linking chemical exposure with cognitive and behavioral
abnormalities.
TCDD binds aryl hydrocarbon receptor (AhR), a transcription fac-
tor present in cells of various organs, including the brain (Petersen
et al., 2000), and induces a variety of toxicities in an AhR-
dependentmanner, as has been shown by the three independent col-
onies of AhR-null mice (Fernandez-Salguero et al., 1995; Mimura
et al., 1997; Schmidt et al., 1996). Although recent studies have
revealed the molecular basis of dioxin toxicities, such as
hydronephrosis, prostate development, and developing zebraﬁsh
brain circulation (Denison et al., 2011; Yoshioka et al., 2011), knowl-
edge about the regulation of AhR downstream signals in the majority
of dioxin toxicities remains elusive. To study AhR gain-of-function,
transgenic mouse strains that expressed constitutively active (CA)-
AhR was produced to mimic the situation of AhR agonist exposure
and was found to manifest typical signs of dioxin toxicities such as
thymic involution (Ito et al., 2004) and liver enlargement
(Brunnberg et al., 2006), as well as tumors in the glandular part of
the stomach (Andersson et al., 2002). These results strongly suggest
that AhR signaling is essential to the induction of TCDD toxicity.
Accordingly, in the present study, we used hippocampus-speciﬁc in
utero CA-AhR electroporation (Kitazawa et al., 2014) to study whether
the activation of AhR signaling affected neuronal morphology in the de-
veloping brain. Next, we studied when and how perinatal low-dose
TCDD exposure affected neuronal morphology in the brains of develop-
ing and agedmice and compared the phenotypes of thesemice. Because
previous studies have reported that TCDD affects fear memory, we se-
lected the hippocampus and amygdala for an intensive morphological
analysis.2. Materials and methods
2.1. Reagents and chemicals
TCDD (purity N99.5%)was purchased from Cambridge Isotope Labo-
ratory (Andover,MA, USA). Corn oil and n-nonanewere purchased from
Wako Pure Chemicals (Osaka, Japan) andNakalai Tesque (Kyoto, Japan),
respectively. Themanufacturers of other reagents and instruments used
in this study are described in each section below.2.2. Animals
The animal experimental protocols used in this studywere approved
by the Animal Care and Use Committees of Keio University (CA-AhR
experiments, described below) and the University of Tokyo (TCDD ex-
posure experiments, described below). For the in utero CA-AhR electro-
poration experiments, time-mated pregnant C57BL/6 mice were
purchased from Japan SLC (Shizuoka, Japan). For TCDD-exposure exper-
iments, C57BL/6 mice were purchased from CLEA Japan (Tokyo, Japan),
and Thy1-green ﬂuorescent protein-Mmice (Thy1-GFP-Mmice, hereaf-
ter) were a kind gift from Dr. G. Feng at the Massachusetts Institute of
Technology (Feng et al., 2000). Female C57BL/6 wild-type mice were
mated with male Thy1-GFP-M mice to produce pups bearing the
Thy1-GFP allele. These mice were housed in an animal facility with a
set temperature of 22 °C–24 °C and humidity of 40%− 60%, as well as
a 12/12-h light–dark cycle (lights on from 08:00 to 20:00). Laboratory
rodent chow (Lab MR Stock; Nosan, Yokohama, Japan) and distilled
water were provided ad libitum.2.3. Vector construction
To obtain a full-length AhR cDNA fragment from a C57BL/6 mouse, a
nested polymerase chain reaction (PCR) was performed using a mouse
liver cDNA library as the template and two primer pairs: 5′-CCTCCGGG
ACGCAGGTG-3′/5′-AGCATCTCAGGTACGGGTTT-3′ and 5′-CTCGAGGC
GGGCACCATGAGCAGCGGCGCCA-3′/5′-CTCGAGTCAACTCTGCACCTTG
CT-3′. AnAhRdeletionmutant that lacks a part of the ligand-bindingdo-
mainwas shown to function as CA-AhR (Ito et al., 2004). To produce this
CA-AhR cDNA fragment, it was ampliﬁed by PCR using the speciﬁc
primers 5′-CTCGAGGCGGGCACCATGAGCAGCGGCGCCA-3′ and 5′-
CTCGAGTCAACTCTGCACCTTGCT-3′ and pQCXIN-CA-AhR-EGFP (a kind
gift from Dr. Yoshiaki Fujii-Kuriyama at University of Tsukuba and Dr.
Tomohiro Ito at the National Institute for Environmental Studies) as a
template. The resulting AhR and CA-AhR fragments were excised by
XhoI digestion and inserted into the XhoI site of pCAGGS1 to generate
the pCAGGA1-AhR and pCAGGS1-CA-AhR plasmids, respectively.
These plasmids were subsequently used for in utero electroporation to
induce AhR and CA-AhR expressions, respectively, in hippocampal
CA1 pyramidal neurons.
2.4. In utero electroporation
Pregnant mouse surgery and embryo manipulation in utero were
performed as previously described (Tabata and Nakajima, 2001;
Tomita et al., 2011). Brieﬂy, on gestational day (GD) 14, pregnant
C57BL/6 mice were deeply anesthetized with sodium pentobarbital
(50 mg/kg b.w.) and laparotomized to expose the uterine horns. Plas-
mid DNA was dissolved in 10 mM Tris–HCl (pH 8.0) at a concentration
of 2 μg/μl, and Fast Green solution (0.1%) was added to the plasmid so-
lution in a 1:10 ratio tomonitor the injection. For embryonic hippocam-
pal transfection, approximately 1–2 μl of plasmid solution was injected
into the lateral telencephalon ventricle of each embryo with a glass mi-
cropipette made from a microcapillary tube (GD-1; Narishige, Tokyo,
Japan). We used a tweezer-type electrode (CUY650-5; Tokiwa Science,
Fukuoka, Japan) for electroporation and placed the cathode adjacent
to the neocortex on the hippocampal side (Kitazawa et al., 2014).
Using an electroporator (CUY21E; Nepa gene, Chiba, Japan), electronic
pulses (30 V; 50 ms) were charged four times at 950-ms intervals.
The uterine horns were placed back into the abdominal cavity to allow
the electroporated embryos to continue normal development. Embryos
electroporated with pCAGGS1-tdTomato, pCAGGS1-tdTomato +
pCAGGS1-AhR, or pCAGGS1-tdTomato+ pCAGGS1-CA-AhR are hereaf-
ter designated as the control, AhR, and CA-AhR groups, respectively.
2.5. TCDD treatment
Pregnant female C57BL/6 mice were orally administered vehicle
(corn oil containing 0.6% n-nonane) or TCDD in vehicle at a dose of 0,
0.6, or 3.0 μg/kg b.w. on GD 12.5 (hereafter, the doses correspond to
the control, TCDD-0.6, and TCDD-3.0 groups, respectively). The pups
were culled to 6–8 per dam on postnatal day (PND) 0, weaned on
PND 21, and maintained under the same conditions as their dams.
Onemale pup per damwas randomly selected for analysis of TCDD con-
centration or dendritic morphology to minimize the possible litter ef-
fects (n= 3–5 mice/group).
2.6. Determination of TCDD in the brain
Male offspring on PND 14were anesthetizedwith sodiumpentobar-
bital, and thewhole brain of eachmousewas quickly removed from the
skull and stored at−80 °C until analysis of TCDD concentration. After
pretreatment of the whole brain with liquid extraction and gel clean-
up, TCDD was determined using high-resolution gas chromatography
and high-resolution mass spectrometry (Nakamoto et al., 2013) at the
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2.7. Golgi staining in aged mice
Neuronal Golgi staining was performed using the FD Rapid Golgi
Stain Kit (FD NeuroTechnologies, Ellicott City, MD, USA) according to
the manufacturer's instructions. Brieﬂy, male mice (16-month-old)
were sacriﬁced by cervical dislocation. Brains were quickly removed
from the skulls, brieﬂy rinsed in distilled water, and incubated in the
dark in a mixture of kit solutions A and B for 3 days at room tempera-
ture, after which they were transferred to kit solution C for 3 days at 4
°C. Brain tissues were cut with a cryostat (Leica CM3050S; Leica
Microsystems K. K., Tokyo, Japan) through the coronal hippocampal
plane to generate 150-μm-thick slices. Brain sections were placed on
gelatinized slides, rinsed in distilled water, and immersed in a mixture
of kit solutions D and E and distilled water for staining in the dark,
followed by another rinse in distilled water. The slides were subse-
quently dehydrated in a series of ethanol solutions (50%, 70%, 90%,
and 100%) for 5 min each, covered with Permount mounting media
(Fisher Scientiﬁc, Pittsburgh, PA, USA), and stored in the dark until
completely dry. The hippocampal sections were ﬁnally viewed under a
microscope (Leica DM6000 B; Leica Microsystems K. K.).
2.8. Preparation of brain tissues from electroporated mice or Thy1-GFP-M
mice
On PND 14, electroporated male mice or Thy1-GFP-M male mice
were anesthetized with sodium pentobarbital and transcardially per-
fusedwith 4% paraformaldehyde (PFA) in 0.1M phosphate-buffered sa-
line (PBS, pH 7.4). The brains were removed and ﬁxed overnight in 4%
PFA. Routinely, brains were immersed in a series of 5%, 15%, and 30% su-
crose in 0.1 M PBS, frozen in Tissue-Tek O.C.T. compound (Sakura
Finetek; Tokyo, Japan), and stored at −80 °C until analysis. Brains
were cut with a Leica CM3050S cryostat through the coronal plane of
the hippocampus and basolateral amygdala (BLA) to generate 150-
μm-thick slices. Brain sections were collected and rinsed in 0.1 M PBS
and placed on slides. Each slide was covered with Vectashield (Vector
Laboratories, Burlingame, CA, USA) and a plastic coverslip and viewed
with a Leica DM6000 B microscope.
2.9. Analysis of dendritic morphology
The pyramidal neuronal structures in the hippocampal CA1 and BLA
regions were subjected to a morphological analysis using Neurolucida
software, a computer-based neuron tracing system (MicroBrightField,
Colchester, VT, USA). A single neuron was traced under a microscope
with a speciﬁc objective lens (Leica DM6000 B, HCX PL APO, 40×,
NA = 0.75; Leica Microsystems). Golgi-stained neurons or tdTomato-/
GFP-expressing neuronswere observed via camera lucida at 400×mag-
niﬁcation under blinded conditions (i.e., information about the tissue
sections was kept conﬁdential from the researchers who analyzed cell
morphology). The three-dimensional morphology of apical dendrites
of the CA1 pyramidal neurons and of all dendrites of the BLA pyramidal
neurons was also quantiﬁed using Neurolucida software. To precisely
analyze dendritic length, we chose the ﬁrst-, second- and third-order
branches proximal to the cell body and quantiﬁed and compared the
dendritic lengths among the groups using NeuroExpolorer software
(MicroBrightField). Three to seven neurons were traced per mouse.
The CA1 and BLA regions were subjected to dendritic spine density
analysis under 400×magniﬁcation. All visible spines along the selected
dendritic segments were counted, and spine density values were
expressed as the number of spines per 10-μm dendrite; 23–37 seg-
ments were counted per mouse. To ensure objective evaluation, the in-
formation on tissue sectioning and tissue slide preparation wasmaintained conﬁdential from the researcher who analyzed the tissue
morphology.
2.10. Immunohistochemistry
To examine activation of AhR signaling in electroporated cells, we
used immunohistochemistry to detect Cyp1a1 protein as an AhR-
target protein. To this end, frozen tissueswere cryosectioned to produce
50-μm-thick slices. Anti-Cyp1a1 antibody (sc-9828, Santa Cruz Biotech-
nology, CA, USA) and anti-RFP antibody (600-401-379, Rockland Immu-
nochemicals, PA, USA) were used to detect Cyp1a1 and tdTomato,
respectively. Brain sections were washed in 0.01% Triton X-100 in PBS
(PBST) and soaked in 1mMEDTA solution (pH 8.0) and treated in ami-
crowave for 90 s at 600 W at 100 V. After incubation with 10% bovine
serum for blocking, the tissue sectionswere incubatedwith primary an-
tibodies (anti-Cyp1a1, 1:100 and anti-RFP, 1:200). Finally, the signals
were visualized with secondary antibodies (anti-Goat IgG AlexaFluor
488 conjugate and anti-Rabbit IgG AlexaFluor 568, Life Technologies,
MD, USA), followed by washing in PBST and mounting for ﬂuorescence
microscopy.
2.11. Statistical analysis
All statistical analyses were conducted using SPSS 15.0 (SPSS Japan
Inc., Tokyo, Japan). The dendritic length and spine density were ana-
lyzed using a one-way analysis of variance (ANOVA), followed by the
Dunnett's post hoc test. P values of b0.05 were considered statistically
signiﬁcant.
3. Results
3.1. Dendritic branch lengths of CA-AhR-expressing mice during brain
development
The AhR protein contains several domains, including basic helix-
loop-helix, Per-Arnt-Sim, ligand binding, and Q-rich domains, whereas
a CA-AhR transfection vector was made by the deletion of amino acids
277–418 (Fig. 1A). Following in utero electroporation of AhR or CA-
AhR vector on GD 14,we examinedAhR signaling levels in hippocampal
neurons on PND 14. Because a distinct Cyp1a1 signal in tdTomato-
expressing neurons was observed in the CA-AhR group, but not in the
control or AhR groups (Fig. 1B), CA-AhR was shown to function as a
transcription factor to induce AhR signaling in the targeted hippocam-
pal pyramidal neurons. Furthermore, because Cyp1a1 immunostaining
in the liver was negligible in the vehicle-treated control mice, but was
markedly enhanced in TCDD-exposed mice, the anti-Cyp1a1 antibody
used in the present study was veriﬁed to speciﬁcally react with
Cyp1a1 (Fig. S1).
Next, we analyzed apical dendrite morphology of hippocampal CA1
pyramidal neurons in 14-day-old mice. The dendritic lengths of the
ﬁrst-, second-, and third-order branches of tdTomato-expressing neu-
rons were analyzed using Neurolucida software (Fig. 2A, B, and C).
Because the fourth-order or higher branches distal to the cell body
were superimposed with those from the dendrites of other neurons, it
was difﬁcult to trace those branches and determine their lengths. No
signiﬁcant difference was observed between the CA-AhR and control
groups in terms of the ﬁrst-order branch dendritic lengths (data not
shown). However, CA-AhR signiﬁcantly affected the second- [one-way
ANOVA, F(2, 11) = 4.28, P b 0.05], but not third- [one-way ANOVA,
F(2, 11) = 1.74, P = 0.22], order branch lengths. The second-order
branch lengths in the CA-AhR group were two-fold longer than those
in the control group (Fig. 2D; Dunnett's post hoc test, P b 0.05). No sig-
niﬁcant differencewas observed between the control andAhR groups in
terms of dendritic branch lengths. These results indicate that activation
of AhR signaling suppressed the coordinated growth of dendritic
branches in the developing brain, suggesting the possibility of the
Fig. 1. Induction of Cyp1a1 expression in pyramidal neurons in the hippocampal CA1 re-
gion of CA-AhR-electroporated mice. (A) Scheme of AhR and CA-AhR protein structures.
Numbers represent the position of a given amino acid residue. (B) Representative photo-
graphs showing Cyp1a1 expression in tdTomato-expressing neurons in theCA-AhRgroup,
but not the control or AhR groups. In CA-AhR-electroporated mice, a Cyp1a1 signal was
observed in the cell body of hippocampal pyramidal neurons. Scale =20 μm. bHLH,
basic helix-loop-helix domain; LB, ligand-binding domain; PAS, Per-Arnt-Sim domain;
Q-rich, glutamine-rich domain.
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exposed to TCDD.
3.2. Dendritic branch lengths in the brains of developing offspring of
TCDD-exposed mice
TCDD concentrations in the whole brain from the control, TCDD-0.6
and TCDD-3.0 groups on PND 14 were determined. TCDD was found to
be accumulated in the brain in a dose-dependent manner (Table 1). The
apical dendritic branch lengths of the second- and third-order branches
were analyzed on GFP-expressing pyramidal neurons in the hippocampalCA1 (Fig. 3A and B) and BLA (Fig. 4A and B) regions in Thy1-GFP-Mmice
born to dams administered vehicle or TCDD. Perinatal exposure to TCDD
signiﬁcantly affected the second- [one-way ANOVA, F(2, 12) = 6.96,
P b 0.01] and third- [one-way ANOVA, F(2, 12) = 6.28, P b 0.05] order
branch lengths in the hippocampal CA1 region of 14-day-old mice. The
second-order branch lengths in the TCDD-3.0 group were 37% shorter
than those in the control group, and the third-order branch lengths in
the TCDD-0.6 group was 57% longer than those in the control group
(Fig. 3C; Dunnett's post hoc test, P b 0.05). In the BLA, TCDD signiﬁcantly
affected the third- [one-wayANOVA, F(2, 11)=4.15, P b 0.05] but not the
second- [one-way ANOVA, F(2, 11) = 1.80, P = 0.21] order branch
lengths on pyramidal neurons. The third-order branch lengths in the
TCDD-3.0 group was 24% shorter than that in the control group (Fig. 4C;
Dunnett's post hoc test, P b 0.05). These results suggest that perinatal ex-
posure to TCDD alters dendritic growth on both CA1 and BLA neurons in
the developing brain.
3.3. Dendritic spine densities in the brains of aged offspring born to
TCDD-exposed dams
Next,we examinedhowperinatal exposure to TCDDaffectedneuronal
morphology in aged (16-month-old) mice. The second- and third-order
branch lengths of apical dendrites were analyzed on Golgi-stained neu-
rons in the CA1 (Fig. 5A and B) and BLA (Fig. 5D and E) of offspring.
Compared with the control group, the aged TCDD-exposed mice did
not exhibited altered the second- or third-order branch lengths in ei-
ther hippocampal CA1 [one-way ANOVA, F(2, 9) = 0.59, P = 0.57;
F(2, 9) = 3.00, P = 0.10, respectively; Fig. 5C] or BLA [one-way
ANOVA, F(2, 6) = 2.13, P=0.20; F(2, 6)= 0.672, P=0.55, respective-
ly; Fig. 5F] pyramidal neurons. However, perinatal TCDD exposure in-
duced a signiﬁcant difference in spine density in the hippocampal CA1
[one-way ANOVA, F(2, 6) = 20.5, P b 0.01] but not BLA [one-way
ANOVA, F(2, 6) = 0.922, P = 0.45] of the aged offspring (Fig. 6A–D).
Morphometric analysis revealed that the spine density in the hippo-
campal CA1 was signiﬁcantly decreased by 30% in the TCDD-0.6 group
and by 47% in the TCDD-3.0 group relative to the control group
(Fig. 6B; Dunnett's post hoc test, P b 0.05 and b0.01, respectively).
These results suggest that TCDD toxicity resulting from perinatal expo-
sure persists into adulthood.
4. Discussion
Abnormal dendritic morphology in the CA1 region was observed in
infantile and aged mice following perinatal exposure to TCDD as well
as in infantile mice transfected with CA-AhR via in utero electropora-
tion. It is reasonable to speculate that CA-AhR and TCDDhave a common
signaling pathway via AhR to induce abnormal dendritic growth. How-
ever, the direction of change appeared to be opposite, depending on the
method of activating the AhR, i.e., CA-AHR (Fig. 2D) vs. TCDD (Fig. 3C),
suggesting that the mechanism of induction of abnormal dendritic
growth may differ between CA-AhR transfection and TCDD exposure.
Although we cannot exclude such a possibility, it should be pointed
out that at least three parameters may explain such an apparent dis-
crepancy in the outcome of CA-AhR transfection or TCDD exposure.
The three parameters include the degree of induction of AhR signaling,
the duration of AhR signaling activation depending on CA-AhR transfec-
tion quantity or TCDD dose, and the number of AhR-activated neurons
in the CA1 region by either hippocampus-speciﬁc CA-AhR transfection
or TCDD exposure. These parameters cannot be controlled under the
present experimental conditions, which presumably resulted in the ap-
parently different directional change in dendritic length in second- and
third-order branches observed in the CA1 region of the CA-AhR-
transfected (Fig. 2D) or TCDD-exposed hippocampus (Fig. 3C). In addi-
tion, there are three possible explanations on the differences in toxicity
between TCDD exposure and CA-AhR transfection. First, the presence of
receptors other than AhR cannot be excluded for the following two
Fig. 2. In utero CA-AhR electroporation into the hippocampus induces abnormal growth in the dendrites of pyramidal neurons in the hippocampal CA1 region of the developing brain of
infant mice. Hippocampus-speciﬁc electroporation of pCAGGS1-tdTomato and pCAGGS1-AhR or pCAGGS1-CA-AhR was performed on GD 14 and analyzed in the brains of 14-day-old
mice. (A) Representative photomicrograph of the hippocampus. A tdTomato signal is observed in CA1 pyramidal neurons. The inserted rectangle ismagniﬁed and shown in (B). (C)A rep-
resentative image of a camera lucida drawing of pyramidal neurons, displaying apical dendritic branches and their order numbers starting from the cell body. (D) Second- and third-order
branch lengths of the apical dendrites of pyramidal neurons. Scale =1.0 mm, 100 μm, and 20 μm in (A), (B), and (C), respectively. Arrowheads indicate apical dendrites of tdTomato-
expressing neurons. Asterisk (*) indicates a signiﬁcant difference between the control and CA-AhR groups (P b 0.05). Values are shown as mean ± standard error of the mean (SEM)
for four or ﬁve mice per group.
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necrosis of the lung and liver tissues (Fernandez-Salguero et al., 1995)
and (2) a non-monotonic dose response repeatedly observed in
TCDD-exposed animals (Ikeda et al., 2005; Endo et al., 2012;
Kakeyama et al., 2014)may be explained by the presence of other puta-
tive receptors once AhR is saturatedwith TCDD (Kakeyama et al., 2014).
Second, TCDD exposure might have affected not only neurons but also
glial cells that have been known to be involved in the dendritic growth
and synaptic plasticity (Pfrieger, 2010; Procko and Shaham, 2010). On
the other hand, CA-AhR was speciﬁcally transfected to neurons, which
consequently activated AhR present in neurons, but not in glial cells.
To address these two points, AhR-null mice or AhR-speciﬁc short hair-
pin RNAwill contribute to elucidate an alternative target and to investi-
gate the mechanisms of abnormal dendritic growth in the developing
brain. Third, TCDD can be metabolized in humans, rats, and mice
(Gasiewicz et al., 1983; Pohjanvirta et al., 1990), with a recent ﬁnding
of its metabolites, 2,3,7-trichloro-8-hydroxydibenzo-p-dioxin and
1,3,7,8-tetrachloro-2-hydroxydibenzo-p-dioxin, in humans (Sorg et al.,Table 1
Brain TCDD concentrations in offspring on PND 14.
Group TCDD dose (μg/kg b.w.) TCDD in whole brain (pg/g tissue)
Control 0 0.42 ± 0.04
TCDD-0.6 0.6 11.7 ± 0.88
TCDD-3.0 3.0 36.3 ± 5.17
Values are shown as mean ± SEM for three mice per group.
The lower detection limit is 0.7 pg/g tissue.2009). Although these metabolites seemed to enhance the elimination
of TCDD from the body, we cannot exclude the possibility of their
toxic actions. Thus, it is reasonable to consider that not only TCDD but
also its metabolites may have unidentiﬁed actions on the neuronal tox-
icity. Although the extent to which CA-AhR mimics TCDD exposure is
unclear, themicromorphological analysis on dendritic growth exhibited
that the two types of disruption of AhR signaling resulted in abnormal
morphology in the developing brain.
Our present ﬁndings show that aberrant activation of the signaling
pathway in the developing brain following low-level exposure to
TCDD may persist until adulthood. In aged mice, a decrease in spine
density in the hippocampal CA1 but not BLAwas observed (Fig. 6). Den-
dritic spines bear excitatory synapses that express glutamate receptors
(Petralia and Wenthold, 1992; Petralia et al., 1994) and play an impor-
tant role in neuronal transmission (Kessels and Malinow, 2009; Lau
and Zukin, 2007). A decrease in hippocampal spine density was ob-
served in patients with Alzheimer's disease, suggesting a relationship
between spine density and memory function (Ji et al., 2003; Scheff
et al., 2007). The decreased number of spines in the CA1 region of
agedmice (Fig. 6) are thought to be responsible for synaptic dysfunction
and consequent impaired memory function. In particular, perinatal
TCDD exposure under the same dosing conditions in the present study
was found to affect higher brain function in adulthood, including fear
memory (Haijima et al., 2010), behavioral ﬂexibility, repetitive compul-
sory responses, and abnormal social behavior (Endo et al., 2012).
Previous animal studies have shown a causal relationship of perinatal
lead exposure with increased amounts of amyloid precursor protein
and β-amyloid, indicators of Alzheimer's disease, later in life
Fig. 3. Abnormal dendritic growth of pyramidal neurons in the hippocampal CA1 region of
infant (14-day-old) mice born to dams administered low doses of TCDD. (A) A represen-
tative photomicrograph of the hippocampus of a Thy1-GFP-M mouse. A GFP signal is ob-
served in CA1 pyramidal neurons. The inserted rectangle is magniﬁed and shown in (B).
(C) Second- and third-order branch lengths of apical dendrite of pyramidal neurons
from GFP-Thy1-Mmice. Scale =1.0 mm and 100 μm in (A) and (B), respectively. Arrow-
heads indicate apical dendrites of GFP-positive neurons. Asterisk (*) indicates signiﬁcant
differences between the control and TCDD-exposed groups (P b 0.05). Values are shown
as mean ± SEM for ﬁve mice per group.
Fig. 4. Abnormal dendritic growth of pyramidal neurons in the BLA region of infant
(14-day-old) mice born to dams administered low doses of TCDD. (A) A representative
photomicrograph of the BLA of a Thy1-GFP-Mmouse. A GFP signal is observed in BLA py-
ramidal neurons. The inserted rectangle is magniﬁed and shown in (B). (C) Second- and
third-order branch lengths of pyramidal neurons in GFP-Thy1-M mice. Scale =1.0 mm
and 100 μm in (A) and (B), respectively. Arrowheads indicate apical dendrites of GFP-pos-
itive neurons. Asterisk (*) indicates signiﬁcant differences between the control and TCDD-
exposed groups (P b 0.05). Values are shown as mean ± SEM for four or ﬁve mice per
group.
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the effects of perinatal chemical exposure on neuronal morphology in
aged animals. Thus, this animal model of AhR-disruption by perinatal
TCDD-exposure with micromorphological phenotypes early in life, but
with cognitive and behavioral phenotypes later in life, corresponds
well to the theory of DOHaD, whichwas originally conceived to address
nutritional states during pregnancy.We failed to analyze the spine den-
sity in CA-AhR-transfected hippocampus because of an insufﬁcient res-
olution of themicroscope, and the use of membrane-bound GFP will be
pursued in a prospective study.
GD 12.5, when TCDD was administered, is during the development
period of the telencephalon, including the hippocampus and amygdala.
Thus, it can be speculated that the impact of TCDD exposure on den-
drites is not limited to the hippocampus and amygdala but is present
in other region of the telencephalon, such as the cerebral cortex and ol-
factory bulb. The retarded growth of dendrites may be induced by the
disruption of the dendritic elongation signaling due to altered expres-
sion of NMDA receptor subunits and BDNF. This speculation is support-
ed by experimental evidence in that elongation of dendrites is regulated
by NMDA receptor and BDNF signaling (Wong and Ghosh, 2002) and
that the gene expression of NMDA subunits and BDNF was altered by
perinatal exposure to TCDD in rats (Hood et al., 2006; Kakeyama et al.,
2001, 2003). In these studies, dams were orally administered TCDD at
a dose of 200 or 800 ng/kg b.w. (Kakeyama et al., 2001) or 100 or
700 ng/kg b.w. (Hood et al., 2006) on GD 15. An increase in NR2A
mRNA abundance but a decrease in NR2B mRNA abundance suggests
that signal transmission via NMDA receptors did not function normally.
In addition, perinatal exposure to TCDD suppresses the induction of
BDNF mRNA expression (Kakeyama et al., 2003), suggesting the nega-
tive regulation of dendritic growth.In the hippocampal CA1 region of the developing brain, the third
branch in the TCDD-0.6 group was longer than that in the control
group, but that in the TCDD-3.0 group was similar to that in the control
group; this showed a nonmonotonic dose–response (Fig. 3C). Such a re-
sponse pattern was observed for neuronal cell activity as well as abnor-
mal mouse behavior under the same experimental conditions (Endo
et al., 2012). In this previous study, mice born to dams exposed to
0.6 μg TCDD/kg b.w. showed abnormal behavioral ﬂexibility and social-
ity compared with the control group, but mice born to dams exposed
to 3.0 μg TCDD/kg b.w. were similar to the control group. Such a
nonmonotonic dose response was supported by the immunostaining
intensity of neuronal activity markers, c-Fos and Arc proteins (Endo
et al., 2012). Other examples of nonmonotonic dose response were ob-
served in rats that were subjected to a saccharine test (Ikeda et al.,
2005) and a paired association test (Kakeyama et al., 2014). Other end-
points, such as immune system and cellular proliferation, were also re-
ported to follow a nonmonotonic dose response in TCDD-exposed rats
(Fan et al., 1996; Teeguarden et al., 1999). Exposure to TCDD as well
as other chemicals is known to result in a nonmonotonic dose response,
and the mechanisms of action of endocrine disrupting chemicals has
been reported(Vandenberg et al., 2012). Until AhR is saturated with
TCDD, a monotonic dose response is considered to occur, whereas be-
yond the saturation of AhR, TCDDmay crosstalkwith estrogen receptors
or other hormone receptors to induce a secondary reaction that is not
mediated by AhR, and may negate the TCDD toxicity induced at a
lower dose.
In conclusion, micromorphological analysis of neuronal growth and
neural network formation may clarify the relationship between low-
dose chemical exposure and neurotoxicity phenotypes. An investigation
Fig. 5. No alterations in dendritic growth of pyramidal neurons in the hippocampal CA1 region and those in the BLA region of aged (16-month-old) mice born to dams administered low
doses of TCDD. (A andD)Representative photographs showingGolgi-stained dendrites and spines in theCA1 and BLA, respectively. Bar=10 μm. The inserted rectangles in (A) and (D) are
magniﬁed and shown in (B) and (E), respectively. (C and F) Second- and third-order branch lengths of pyramidal neurons in the CA1 andBLA. Scale=1.0mm in (A) and (D) and 100 μmin
(B) and (E). Arrowheads indicate apical dendrites of Golgi-stained neurons. Values are shown as mean ± SEM for three mice per group.
Fig. 6.Abnormally reduced dendritic spine densities in the hippocampal CA1 region of aged (16-month-old)mice born to dams administered low doses of TCDD. (A and C) Representative
photographs showing Golgi-stained dendrites and spines in the CA1 and BLA, respectively. Scale= 10 μm. (B andD) Spine density (i.e., the number of spines per arbitrary dendrite length
(10 μm)) in the CA1 and BLA, respectively. No alterations in spine density in the BLAwere observed between the control and TCDD-exposed groups. Asterisks (*) and (**) indicate signif-
icant differences from the control group (P b 0.05 and 0.01, respectively). Values are shown as mean ± SEM for three mice per group.
48 E. Kimura et al. / Neurotoxicology and Teratology 52 (2015) 42–50
49E. Kimura et al. / Neurotoxicology and Teratology 52 (2015) 42–50of developmental neurotoxicity consequent to chemical exposure is ex-
pected to shed light on the underlyingmechanisms of not only chemical
toxicity but also mental disorders and related health.
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